Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine, announced today that the My5-FU™ Assay will be part of the Saladax Biomedical Laboratories MyCare™ service offering when the CLIA laboratory located at Ben Franklin TechVentures, Bethlehem commences operations later this year. My5-FU is a simple blood test that provides oncologists with objective information to guide optimized dosing for chemotherapy, controlling toxic side effects and improving treatment efficacy for cancer patients.  Read more.